SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

Addressing the Donor Heart Shortage

Heart transplants are the current standard of care for end-stage biventricular heart failure. However, despite growing demand for donor hearts over the last 25 years, the supply of donor hearts has remained flat. Medical papers estimate that 20,000 people in the U.S. alone would benefit from a heart transplant, but supply of donor hearts has remained at 2,000-2,500 annually.

  • In the U.S., according to the Organ Procurement and Transplantation Network (OPTN),Organ Procurement and Transplantation Network (OPTN), as of Jan. 18, 2017, nearly half of the people (49%) on the waiting list for a heart transplant have been waiting for one year or more.
  • In the European Union, according to the European Commission,European Commission, nearly 3,500 people were on waiting lists for a donor heart, yet just over 2,000 heart transplants were performed in 2012.

HeartTransplantsReportedbyYear3


According to the World Heart Failure Alliance, 26 million people worldwide live with heart failure. For people who progress to end-stage heart failure affecting both sides of their heart, there are two treatment options:

Immediate Donor Heart Transplant

Immediate Artificial Heart Implant

Donor Heart

Nearly half the people waiting for a donor heart have been on the list for more than a year.

total Artificial Heart

Unlike a donor heart, the Total Artificial Heart is available at more than 100 SynCardia Certified Centers.

 

The Total Artificial Heart is a Bridge to Transplant

The Total Artificial Heart is currently approved as a bridge to a donor heart transplant for patients suffering from end-stage biventricular (both sides) heart failure. It’s the world’s first and only FDA (U.S.), CE Mark (Europe) and Health Canada approved Total Artificial Heart. According to data published in the New England Journal of Medicine (N Engl J Med 2004; 351:859-67) from the 10-year pivotal clinical study which led to FDA approval, 79% of patients who received the Total Artificial Heart were bridged to transplant79% of patients who received the Total Artificial Heart were bridged to transplant. This is the highest bridge-to-transplant rate for any approved heart device in the world.

Search offcanvas